Notices. Notice

224 words·~1 min read·/register/2020/03/30/2020-06513

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4184-25-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2020-N-0008] Allergenic Products Advisory Committee; Cancellation of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The meeting of the Allergenic Products Advisory Committee scheduled for May 15, 2020, is canceled. The Allergenic Products Advisory Committee meeting scheduled for May 15, 2020, to discuss and make recommendations on the safety and efficacy of Peanut ( *Arachis hypogaea* ) Allergen Extract manufactured by DBV Technologies, S.A, has been canceled to allow time for the FDA to review outstanding issues.

The Agency intends to continue evaluating the product and will schedule an Advisory Committee meeting in the future, as needed. The meeting was announced in the **Federal Register** on February 24, 2020. FOR FURTHER INFORMATION CONTACT: Kathleen Hayes, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 6307, Silver Spring, MD 20993-0002, 301-796-7864, *kathleen.hayes@fda.hhs.gov,* or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area.

Please call the Information Line for up-to-date information on this meeting, which was announced in the **Federal Register** of February 24, 2020, 85 FR 10451. Dated: March 24, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020-06513 Filed 3-27-20; 8:45 am]